Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Samira Fafi‐Kremer, Sophie Bayer et al.|EBioMedicine|2021Cited by 239
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Samira Fafi‐Kremer, Aurélie Velay et al.|The Journal of Infectious Diseases|2021Cited by 85
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Claire Delage, Lou-Léna Vrignaud et al.|Med|2023Cited by 16